Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Antibiotics can have significant and long-lasting effects on the gastrointestinal tract microbiota, reducing colonization resistance against pathogens including Clostridium difficile. Here we show that antibiotic treatment induces substantial changes in the gut microbial community and in the metabolome of mice susceptible to C. difficile infection. Levels of secondary bile acids, glucose, free fatty acids and dipeptides decrease, whereas those of primary bile acids and sugar alcohols increase, reflecting the modified metabolic activity of the altered gut microbiome. In vitro and ex vivo analyses demonstrate that C. difficile can exploit specific metabolites that become more abundant in the mouse gut after antibiotics, including the primary bile acid taurocholate for germination, and carbon sources such as mannitol, fructose, sorbitol, raffinose and stachyose for growth. Our results indicate that antibiotic-mediated alteration of the gut microbiome converts the global metabolic profile to one that favours C. difficile germination and growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Similarly, C. difficile colitis is supported by mouse models that recapitulate key clinical and histopathologic features and enable mechanistic studies (Chen et al., 2008; Theriot et al., 2014).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Theriot et al., 2014
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This disturbance can lead to the growth and expansion of pathogens within the intestine (including antibiotic-resistant pathogens), where these pathogens can exploit the absence of competitors and the nutrient-enriched gut environment.”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This promotes intestinal colonization (and even domination) by pathogens such as Clostridioides difficile , carbapenem-resistant Enterobacteriaceae (CRE) and vancomycin-resistant Enterococcus (VRE) [30–32].”
From Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization (2023) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“antibiotic usage depletes BSHs, increasing conjugated BAs and decreasing secondary BAs”
From Bile salt hydrolases shape the bile acid landscape and restrict Clostridioides difficile growth in the murine gut (2023) · cites this paper as [17]
Experimental — accuracy not yet measuredIn the citing paper
“Dethlefsen et al. investigated the effect of ciprofloxacin in three individuals and found reduced microbial taxonomic diversity, richness and evenness, although the magnitude of effect differed among individuals.47”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [47]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister, E. B., Lesniewski, R. A., Oakley, B. B., Parks, D. H., Robinson, C. J., et al. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01541-09 · Cited by 19,549
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Self-citationEnterotypes of the human gut microbiome
MetaHIT Consortium (additional members), Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D., Yamada, T., Mende, D. R., Fernandes, G. R., Tap, J., Bruls, T., et al. (2011) · Nature · doi:10.1038/nature09944 · Cited by 7,548
The Ribosomal Database Project: improved alignments and new tools for rRNA analysis
Cole, J. R., Wang, Q., Cardenas, E., Fish, J., Chai, B., Farris, R. J., Kulam-Syed-Mohideen, A. S., McGarrell, D. M., Marsh, T., Garrity, G. M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn879 · Cited by 4,762
Metagenomic Analysis of the Human Distal Gut Microbiome
Gill, S. R., Pop, M., DeBoy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., Gordon, J. I., Relman, D. A., Fraser-Liggett, C. M., & Nelson, K. E. (2006) · Science · doi:10.1126/science.1124234 · Cited by 4,699
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Nadkarni, M. A., Martin, F. E., Jacques, N. A., & Hunter, N. (2002) · Microbiology · doi:10.1099/00221287-148-1-257 · Cited by 1,938
Antibiotics in early life alter the murine colonic microbiome and adiposity
Cho, I., Yamanishi, S., Cox, L., Methé, B. A., Zavadil, J., Li, K., Gao, Z., Mahana, D., Raju, K., Teitler, I., et al. (2012) · Nature · doi:10.1038/nature11400 · Cited by 1,613
Clostridium difficile Infection
Leffler, D. A., & Lamont, J. T. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1403772 · Cited by 1,450
Research works printed but not linked: 2
- Lucado J Gould C Elixhauser A Clostridium difficile Infections (CDI) in Hospital Stays, 2009 HCUP Statistical Brief #124 2012 1 Rockville, MD Agency for Healthcare Research and Quality (Social & Scientific Systems), (CDC), (AHRQ), http://www.hcup-us.ahrq.gov/reports/statbriefs/sb124.pdf 22574332
- Sorg JA Sonenshein AL Bile salts and glycine as cogerminants for Clostridium difficile spores J Bacteriol 2008 190 2505 2512 18245298 PMC2293200
Cited by
Items 301–400 of 977
Identification of simple arylfluorosulfates as potent agents against resistant bacteria
Zhang, J., Zhao, X., Cappiello, J. R., Yang, Y., Cheng, Y., Liu, G., Fang, W., Luo, Y., Zhang, Y., Dong, J., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103513118 · Cited by 54
Uchihashi, M., Bergin, I. L., Bassis, C. M., Hashway, S. A., Chai, D. C., & Bell, J. D. (2015) · American Journal of Primatology · doi:10.1002/ajp.22378 · Cited by 65
Lamendella, R., Wright, J., Hackman, J., McLimans, C. J., Toole, D. R., Rubio, W. B., Drucker, R., Wong, H. T., Sabey, K. A., Hegarty, J. P., et al. (2018) · mSphere · doi:10.1128/msphere.00572-17 · Cited by 54
Gastrointestinal host-pathogen interaction in the age of microbiome research
Tsolis, R. M., & Bäumler, A. J. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.03.002 · Cited by 62
New technologies for developing phage-based tools to manipulate the human microbiome
Khan Mirzaei, M., & Deng, L. (2022) · Trends in Microbiology · doi:10.1016/j.tim.2021.04.007 · Cited by 53
Recent advances in germination of Clostridium spores
Olguín-Araneda, V., Banawas, S., Sarker, M. R., & Paredes‐Sabja, D. (2014) · Research in Microbiology · doi:10.1016/j.resmic.2014.07.017 · Cited by 63
Ridinilazole: a novel therapy for Clostridium difficile infection
Vickers, R. J., Tillotson, G., Goldstein, E. J. C., Citron, D. M., Garey, K. W., & Wilcox, M. H. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.04.026 · Cited by 54
Downs, I. A., Aroniadis, O. C., Kelly, L., & Brandt, L. J. (2017) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000924 · Cited by 61
Dong, T., Guan, Q., Hu, W., Zhang, M., Zhang, Y., Chen, M., Wang, X., & Xia, Y. (2020) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2020.122152 · Cited by 59
Food for thought—The link between Clostridioides difficile metabolism and pathogenesis
Marshall, A., McGrath, J. W., Graham, R., & McMullan, G. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011034 · Cited by 56
Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review
Caley, L. R., White, H., de Goffau, M. C., Floto, R. A., Parkhill, J., Marsland, B. J., & Peckham, D. G. (2023) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07812-1 · Cited by 61
Biologically Consistent Annotation of Metabolomics Data
Alden, N., Krishnan, S., Porokhin, V. O., Raju, R., McElearney, K., Gilbert, A., & Lee, K. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b02162 · Cited by 62
Reed, A. D., Nethery, M. A., Stewart, A. K., Barrangou, R., & Theriot, C. M. (2020) · Journal of Bacteriology · doi:10.1128/jb.00039-20 · Cited by 55
Garland, M., Hryckowian, A. J., Tholen, M., Oresic Bender, K., Van Treuren, W. W., Loscher, S., Sonnenburg, J. L., & Bogyo, M. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100005 · Cited by 48
The role of the human gut microbiota in colonization and infection with multidrug-resistant bacteria
Wüthrich, I., Pelzer, B. W., Khodamoradi, Y., & Vehreschild, M. J. G. T. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1911279 · Cited by 51
Julliard, W. A., Wolfe, T. J. D., Fechner, J. H., Safdar, N., Agni, R. M., & Mezrich, J. D. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001830 · Cited by 52
Pakpour, S., Bhanvadia, A., Zhu, R., Amarnani, A., Gibbons, S. M., Gurry, T., Alm, E. J., & Martello, L. A. (2017) · Microbiome · doi:10.1186/s40168-017-0368-1 · Cited by 49
Wu, Z., Xu, Q., Gu, S., Chen, Y., Lv, L., Zheng, B., Wang, Q., Wang, K., Wang, S., Xia, J., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.841920 · Cited by 57
Therapeutic manipulation of the microbiota: past, present, and considerations for the future
Young, V. B. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2016.09.001 · Cited by 54
Hepburn, L., Hijnen, D., Sellman, B. R., Mustelin, T., Sleeman, M. A., May, R. D., & Strickland, I. (2016) · British Journal of Dermatology · doi:10.1111/bjd.15139 · Cited by 65
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
Winston, J. A., Thanissery, R., Montgomery, S. A., & Theriot, C. M. (2016) · Journal of Visualized Experiments · doi:10.3791/54850 · Cited by 48
Zhu, D., Xiao, S., Yu, J., Ai, Q., He, Y., Chen, C., Zhang, Y., & Pan, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-08530-9 · Cited by 56
The effects of microbiota on reproductive health: A review
Wang, N., Chen, L., Yi, K., Zhang, B., Li, C., & Zhou, X. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117784 · Cited by 57
Stewart, D. B., Wright, J., Fowler, M., McLimans, C. J., Tokarev, V., Amaniera, I., Baker, O. R., Wong, H. T., Brabec, J. L., Drucker, R., et al. (2019) · mSphere · doi:10.1128/msphere.00454-19 · Cited by 48
Charitos, I. A., Topi, S., Gagliano-Candela, R., Nitto, E. D., Polimeno, L., Montagnani, M., & Santacroce, L. (2022) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530322666220325114045 · Cited by 53
Metabolic Enabling and Detoxification by Mammalian Gut Microbes
Dearing, M. D., & Weinstein, S. B. (2022) · Annual Review of Microbiology · doi:10.1146/annurev-micro-111121-085333 · Cited by 53
Choo, J. M., Kanno, T., Zain, N. M. M., Leong, L. E. X., Abell, G. C. J., Keeble, J. E., Bruce, K. D., Mason, A. J., & Rogers, G. B. (2017) · mSphere · doi:10.1128/msphere.00005-17 · Cited by 59
Contemporary Applications of Fecal Microbiota Transplantation to Treat Intestinal Diseases in Humans
Staley, C. M., Khoruts, A., & Sadowsky, M. J. (2017) · Archives of Medical Research · doi:10.1016/j.arcmed.2017.11.006 · Cited by 50
Biomedical applications of genome-scale metabolic network reconstructions of human pathogens
Dunphy, L. J., & Papin, J. A. (2017) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.11.014 · Cited by 45
Segal, J. P., Mullish, B. H., Quraishi, M. N., Iqbal, T. H., Marchesi, J. R., & Sokol, H. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820946904 · Cited by 51
Microcins reveal natural mechanisms of bacterial manipulation to inform therapeutic development
Parker, J. K., & Davies, B. W. (2022) · Microbiology · doi:10.1099/mic.0.001175 · Cited by 56
Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment
Spigaglia, P. (2024) · Pathogens · doi:10.3390/pathogens13080646 · Cited by 60
Crouzet, L., Rigottier‐Gois, L., & Serror, P. (2015) · FEMS Microbiology Letters · doi:10.1093/femsle/fnv012 · Cited by 52
Germinant Synergy Facilitates Clostridium difficile Spore Germination under Physiological Conditions
Kochan, T. J., Shoshiev, M. S., Hastie, J. L., Somers, M. J., Plotnick, Y. M., Gutierrez-Munoz, D. F., Foss, E. D., Schubert, A. M., Smith, A. D., Zimmerman, S. K., et al. (2018) · mSphere · doi:10.1128/msphere.00335-18 · Cited by 64
Ojima, M. N., Gotoh, A., Takada, H., Odamaki, T., Xiao, J., Katoh, T., & Katayama, T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01349 · Cited by 48
Kim, J., Cho, Y., Seo, M.-R., Bae, M. H., Kim, B., Rho, M., & Pai, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-74090-0 · Cited by 48
Li, W., Chen, H., & Tang, J. (2024) · Pathogens · doi:10.3390/pathogens13080702 · Cited by 53
Crobach, M. J. T., Ducarmon, Q. R., Terveer, E. M., Harmanus, C., Sanders, I. M. J. G., Verduin, K., Kuijper, E. J., & Zwittink, R. D. (2020) · Microorganisms · doi:10.3390/microorganisms8050677 · Cited by 46
Wang, J., Ishfaq, M., & Li, J. (2021) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2021.110192 · Cited by 44
Microbiota-Based Therapies for Clostridium difficile and Antibiotic-Resistant Enteric Infections
Lewis, B. B., & Pamer, E. G. (2017) · Annual Review of Microbiology · doi:10.1146/annurev-micro-090816-093549 · Cited by 50
Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self
Litvak, Y., & Bäumler, A. J. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.003 · Cited by 46
Clostridioides difficile Infection
Stewart, D. B. (2020) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0040-1701228 · Cited by 43
Zischka, M., Kuenne, C. T., Blom, J., Wobser, D., Sakιnç, T., Schmidt‐Hohagen, K., Dąbrowski, P. W., Nitsche, A., Hübner, J., Hain, T., et al. (2015) · BMC Genomics · doi:10.1186/s12864-015-1367-x · Cited by 47
The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation
Lopez, C. A., Beavers, W. N., Weiss, A., Knippel, R. J., Zackular, J. P., Chazin, W., & Skaar, E. P. (2019) · mBio · doi:10.1128/mbio.02289-19 · Cited by 42
Probiotics: insights and new opportunities for Clostridioides difficile intervention
Pal, R., Athamneh, A. I. M., Deshpande, R., Ramirez, J. A. R., Adu, K. T., Muthuirulan, P., Pawar, S., Biazzo, M., Apidianakis, Y., Sundekilde, U. K., et al. (2022) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2022.2072705 · Cited by 51
Altered Intestinal Microbial Flora and Metabolism in Patients with Idiopathic Membranous Nephropathy
Shi, X., Li, Z., Lin, W., Shi, W., Hu, R., Chen, G., Li, X., Li, X., & Zhang, S. (2023) · American Journal of Nephrology · doi:10.1159/000533537 · Cited by 45
Xu, R., Beatty, W. L., Greigert, V., Witola, W. H., & Sibley, L. D. (2024) · Nature Communications · doi:10.1038/s41467-024-44696-3 · Cited by 42
Sharpening Precision Medicine by a Thorough Interrogation of Metabolic Individuality
Beebe, K. D., & Kennedy, A. D. (2016) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2016.01.001 · Cited by 52
Kusstatscher, P., Cernava, T., Liebminger, S., & Berg, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-13579-7 · Cited by 42
Xu, Q., Gu, S., Chen, Y., Quan, J., Lv, L., Chen, D., Zheng, B., Xu, L., & Li, L. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02396 · Cited by 47
Reed, A. D., & Theriot, C. M. (2021) · Microorganisms · doi:10.3390/microorganisms9020371 · Cited by 39
Self-citationAdaptation of the gut pathobiont Enterococcus faecalis to deoxycholate and taurocholate bile acids
Repoila, F., Wessner, F., Guérin, C., Lacoux, C., Tiwari, S., Jaiswal, A. K., Santana, M. P., Kennedy, S., Quinquis, B., Rainteau, D. P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-12552-3 · Cited by 56
The Prospect for Vaccines to Prevent Clostridium difficile Infection
Ghose, C., & Kelly, C. P. (2015) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2014.11.013 · Cited by 45
A Clostridium difficile -Specific, Gel-Forming Protein Required for Optimal Spore Germination
Donnelly, M. L., Li, W., Li, Y.-Q., Hinkel, L. A., Setlow, P., & Shen, A. (2017) · mBio · doi:10.1128/mbio.02085-16 · Cited by 48
Leslie, J. L., Vendrov, K. C., Jenior, M. L., & Young, V. B. (2019) · mSphere · doi:10.1128/mspheredirect.00698-18 · Cited by 54
Intestinal Dysbiosis in Carriers of Carbapenem-Resistant Enterobacteriaceae
Korach-Rechtman, H., Hreish, M., Fried, C., Gerassy-Vainberg, S., Azzam, Z. S., Kashi, Y., & Berger, G. (2020) · mSphere · doi:10.1128/msphere.00173-20 · Cited by 48
Bacteriophage-mediated modulation of microbiota for diseases treatment
Zhang, Y., Li, C., & Zhang, X. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113856 · Cited by 46
Mordant, A. L., & Kleiner, M. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.01877-21 · Cited by 39
Denny, J. E., Powell, W. L., & Schmidt, N. W. (2016) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2016.00041 · Cited by 43
Network Analysis as a Grand Unifier in Biomedical Data Science
McGillivray, P. D., Clarke, D., Meyerson, W. U., Zhang, J., Lee, D., Gu, M., Kumar, S., Zhou, H., & Gerstein, M. (2018) · Annual Review of Biomedical Data Science · doi:10.1146/annurev-biodatasci-080917-013444 · Cited by 49
Gut Microbial Metabolites Associated With HIV Infection
Wang, Z., & Qi, Q. (2019) · Future Virology · doi:10.2217/fvl-2019-0002 · Cited by 54
Tiffany, C. R., Lee, J., Rogers, A. W. L., Olsan, E. E., Morales, P., Faber, F., & Bäumler, A. J. (2021) · Microbiome · doi:10.1186/s40168-021-01123-9 · Cited by 45
Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
Aguirre, A. M., & Sorg, J. A. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2094672 · Cited by 47
Ma, X., Xu, T., Qian, M., Zhang, Y., Yang, Z., & Han, X. (2021) · Microbiological Research · doi:10.1016/j.micres.2021.126942 · Cited by 45
Shabani, M., Ghoshehy, A., Mottaghi, A. M., Chegini, Z., Kerami, A., Shariati, A., & Moghadam, M. T. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1516010 · Cited by 57
The Rhoptry Pseudokinase ROP54 Modulates Toxoplasma gondii Virulence and Host GBP2 Loading
Kim, E. W., Nadipuram, S. M., Tetlow, A. L., Barshop, W. D., Liu, P. T., Wohlschlegel, J. A., & Bradley, P. J. (2016) · mSphere · doi:10.1128/msphere.00045-16 · Cited by 42
Gastrointestinal Microbiome – What We Need to Know in Clinical Practice
Ortigão, R., Pimentel‐Nunes, P., Dinis-Ribeiro, M. J., & Libânio, D. (2020) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000505036 · Cited by 46
Qian, X., Yanagi, K., Kane, A. V., Alden, N., Lei, M., Snydman, D. R., Vickers, R. J., Lee, K., & Thorpe, C. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00046.2020 · Cited by 41
Yang, X., Li, D., Yu, Z., Meng, Y., Zheng, X., Zhao, S., & Meng, F. (2021) · Water Research · doi:10.1016/j.watres.2021.116835 · Cited by 39
Metabolic adaption to extracellular pyruvate triggers biofilm formation in Clostridioides difficile
Tremblay, Y. D. N., Durand, B. A. R. N., Hamiot, A., Martin‐Verstraete, I., Oberkampf, M., Monot, M., & Dupuy, B. (2021) · The ISME Journal · doi:10.1038/s41396-021-01042-5 · Cited by 44
Paulson, J. N., Talukder, H., & Bravo, H. C. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/099457 · Cited by 39
Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease
Monaghan, T. M., Cockayne, A., & Mahida, Y. R. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000461 · Cited by 38
Jose, S., Mukherjee, A., Horrigan, O., Setchell, K. D. R., Zhang, W., Moreno‐Fernandez, M. E., Andersen, H. M., Sharma, D., Haslam, D. B., Divanovic, S., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00338-7 · Cited by 41
CRISPR-Cas9 mediated phage therapy as an alternative to antibiotics
Balcha, F. B., & Neja, S. A. (2023) · Animal Diseases · doi:10.1186/s44149-023-00065-z · Cited by 49
Sit, B., Crowley, S. M., Bhullar, K., Lai, C. C.-L., Tang, C., Hooda, Y., Calmettes, C., Khambati, H., Ma, C., Brumell, J. H., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005107 · Cited by 38
Li, J., Liu, Y., Kim, E., March, J. C., Bentley, W. E., & Payne, G. F. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.029 · Cited by 40
Evolutionary and ecological forces that shape the bacterial communities of the human gut
Messer, J. S., Liechty, E. R., Vogel, O. A., & Chang, E. B. (2017) · Mucosal Immunology · doi:10.1038/mi.2016.138 · Cited by 46
Qi, X., Tu, X., Zha, J.-W., Huang, A., Wang, G., & Ling, F. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.03.035 · Cited by 43
Frisbee, A. L., & Petri, W. A. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.01.009 · Cited by 46
Fishbein, S. R. S., Robinson, J. I., Hink, T., Reske, K. A., Newcomer, E. P., Burnham, C.-A. D., Henderson, J. P., Dubberke, E. R., & Dantas, G. A. (2022) · eLife · doi:10.7554/elife.72801 · Cited by 42
Ducarmon, Q. R., Zwittink, R. D., Willems, R. P. J., Verhoeven, A., Nooij, S., van der Klis, F. R. M., Franz, E., Kool, J., Giera, M. A., Vandenbroucke‐Grauls, C. M. J. E., et al. (2022) · The Lancet Microbe · doi:10.1016/s2666-5247(22)00037-4 · Cited by 43
Chi, L., Gao, B., Tu, P., Liu, C., Xue, J., Lai, Y., Ru, H., & Lü, K. (2018) · Mammalian Genome · doi:10.1007/s00335-018-9736-9 · Cited by 42
Greathouse, K. L., Harris, C. C., & Bultman, S. J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.016 · Cited by 39
Gemikonakli, G., Mach, J., & Hilmer, S. N. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaa047 · Cited by 44
Shen, D., Guo, Z., Huang, K., Dai, P., Jin, X., Li, Y., & Li, C. (2021) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2021.126710 · Cited by 39
Distal Consequences of Mucosal Infections in Intestinal and Lung Inflammation
Melo-González, F., Sepúlveda-Alfaro, J., Schultz, B. M., Suazo, I. D., Boone, D. L., Kalergis, A. M., & Bueno, S. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.877533 · Cited by 40
Jiang, M., Yang, Z., Dai, J., Wu, T., Jiao, Z., Yu, Y., Kang, N., Chen, W., & Yang, A. (2023) · MedComm · doi:10.1002/mco2.376 · Cited by 39
McMillan, A. S., Zhang, G., Dougherty, M., McGill, S., Gulati, A., Baker, E. S., & Theriot, C. M. (2024) · mSphere · doi:10.1128/msphere.00706-24 · Cited by 44
Bezlotoxumab: A Novel Agent for the Prevention of Recurrent Clostridium difficile Infection
Kufel, W. D., Devanathan, A. S., Marx, A. H., Weber, D. J., & Daniels, L. M. (2017) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1990 · Cited by 37
Shubitowski, T. B., Poll, B. G., Natarajan, N., & Pluznick, J. L. (2019) · Physiological Reports · doi:10.14814/phy2.14005 · Cited by 39
Miao, Z., Cheng, R., Zhang, Y., Liang, H., Jiang, F., Shen, X. P., Chen, G., Zhang, Q., He, F., & Li, M. (2019) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2019.1676696 · Cited by 38
Gut microbiota and the human gut physiological changes
Bajinka, O., Darboe, A., Tan, Y., Abdelhalim, K. A., & Cham, L. B. (2020) · Annals of Microbiology · doi:10.1186/s13213-020-01608-2 · Cited by 42
Kaur, S., Thukral, S. K., Kaur, P., & Samota, M. K. (2021) · Future Foods · doi:10.1016/j.fufo.2021.100043 · Cited by 41
Sulaiman, J. E., Thompson, J. C., Qian, Y., Vivas, E. I., Diener, C., Gibbons, S. M., Safdar, N., & Venturelli, O. S. (2024) · Nature Communications · doi:10.1038/s41467-024-51062-w · Cited by 41
Warn, P. A., Thommes, P. A., Sattar, A., Corbett, D. F., Flattery, A. M., Zhang, Z., Black, T. A., Hernandez, L. D., & Therien, A. G. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00974-16 · Cited by 37
Gao, P., Hou, Q., Kwok, L. Y., Huo, D., Feng, S., & Zhang, H. (2017) · 中国科学通报:英文版 · doi:10.1016/j.scib.2017.01.001 · Cited by 38
Relationships among introduced parasites, host defenses, and gut microbiota of Galapagos birds
Knutie, S. A. (2018) · Ecosphere · doi:10.1002/ecs2.2286 · Cited by 37
Zhu, P., Zhang, J., Chen, Y., Yin, S., Su, M., Xie, G., Brouwer, K. L. R., Liu, C., Lan, K., & Jia, W. P. (2018) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-018-1183-7 · Cited by 37
Metabolic networks of the human gut microbiota
Selber‐Hnatiw, S., Sultana, T., Tse, W., Abdollahi, N., Abdullah, S., Rahbani, J. A., Alazar, D., Alrumhein, N. J., Aprikian, S., Arshad, R., et al. (2019) · Microbiology · doi:10.1099/mic.0.000853 · Cited by 41
Leslie, J. L., Jenior, M. L., Vendrov, K. C., Standke, A. K., Barron, M. R., O’Brien, T. J., Unverdorben, L. V., Thaprawat, P., Bergin, I. L., Schloss, P. D., et al. (2021) · mBio · doi:10.1128/mbio.00522-21 · Cited by 36
Metadata
- Authors
- Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B.
- Affiliations
- University of Michigan (US)
- Corresponding author
- Young, Vincent B.
- ORCID
- Venue
- Nature Communications
- Published
- 2014-01-20
- Volume
- 5
- Issue
- 1
- Pages
- 3114-3114
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3950275
- OpenAlex
- W1979012796
- Cited by
- 974
- References
- 43
- Citations by year
- 2026: 54 · 2025: 69 · 2024: 68 · 2023: 77 · 2022: 104 · 2021: 105 · 2020: 101 · 2019: 85 · 2018: 74 · 2017: 78 · 2016: 68 · 2015: 59 · 2014: 31
- FWCI
- 55.30
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature Communications (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- University of Michigan (DK097153)
- National Institutes of Health (DK097153, AI007528)
- National Heart, Lung, and Blood Institute (T32HL007749)
- National Institute of General Medical Sciences (K01GM109236)
- National Institute of Allergy and Infectious Diseases (U19AI090871, T32AI007528)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-097153, U24DK097153)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile infection, antibiotic-induced dysbiosis, gut microbiota, gut metabolome, colonization resistance, secondary bile acids, primary bile acids, taurocholate, sugar alcohols, carbohydrate metabolism, mouse model
- MeSH terms
- Animals, Anti-Bacterial Agents, Clostridium Infections, Disease Susceptibility, Female, Male, Mice, Inbred C57BL, Clostridioides difficile, Gastrointestinal Tract, Metabolomics, Metabolome, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.